Difference between revisions of "Fitzgerald TL, et al. Adv. Biol. Regul. (2015) cited as Ref 369 in DOI: 10.1038/s41392-020-0110-5 (Q9632)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2015, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 65-81, #quickstatements; #temporary_batch_1590074839150) |
||
(3 intermediate revisions by the same user not shown) | |||
Property / Published In Name String | |||
+ | Adv. Biol. Regul. | ||
Property / Published In Name String: Adv. Biol. Regul. / rank | |||
+ | Normal rank | ||
Property / Volume | |||
+ | 59 | ||
Property / Volume: 59 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells (English) | ||
Property / title: Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 65-81 | ||
Property / Page(s): 65-81 / rank | |||
+ | Normal rank |
Latest revision as of 15:39, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Fitzgerald TL, et al. Adv. Biol. Regul. (2015) cited as Ref 369 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fitzgerald TL
0 references
2015
0 references
Adv. Biol. Regul.
0 references
59
0 references
Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells (English)
0 references
65-81
0 references